Page 4,752«..1020..4,7514,7524,7534,754..4,7604,770..»

Penn Medicine Named as Inaugural Member of NIH Network to Revolutionize Stroke Clinical Research

Posted: Published on December 13th, 2013

Contact Information Available for logged-in reporters only Newswise PHILADELPHIA The Perelman School of Medicine at the University of Pennsylvania will join a new national network of 25 regional stroke centers selected to advance stroke research on prevention, treatment and recovery. Stroke the fourth leading cause of death in the US, and the new program, initiated by the National Institutes of Health, aims to allow the most promising therapies to quickly advance to the clinic, to improve prevention, acute treatment, or rehabilitation of the stroke patient. The Centers were announced today by the National Institutes of Health. Penn Medicines interdisciplinary Stroke Center is poised to offer the newest possible treatment, prevention, and rehabilitation options in the greater Philadelphia region and Delaware Valley, said Scott Kasner, MD, professor of Neurology and director of Penns Comprehensive Stroke Center. Successful applicants demonstrated experience in stroke research and recruitment, including the ability to enroll underrepresented populations, and were required to offer access to the full cadre of specialties that are involved in stroke care. These include: emergency medicine, neurosurgery, interventional neuroradiology, vascular neurology, neurointensive care, neuroimaging, stroke rehabilitation and pediatric neurology. The 25 centers are strategically placed in every region of the country. NIH StrokeNet … Continue reading

Comments Off on Penn Medicine Named as Inaugural Member of NIH Network to Revolutionize Stroke Clinical Research

Pitt to be part of network to prevent, treat strokes

Posted: Published on December 13th, 2013

Published: Friday, Dec. 13, 2013, 12:21p.m. Updated 1 hour ago The University of Pittsburgh will participate in a network of 25 regional stroke centers assembled to advance and streamline research on stroke prevention, treatment and recovery, the National Institutes of Health announced on Friday. This network represents a new and innovative approach to finding more effective methods to prevent and treat strokes, said Dr. Lawrence Wechsler, professor and chair of the Department of Neurology at Pitt's School of Medicine and founder of the UPMC Stroke Institute. Pitt, which is working in coordination with the UPMC Stroke Institute, is the only network site in Western Pennsylvania. The National Institute of Neurological Disorders and Stroke will coordinate and finance the network. The regional stroke centers will receive $200,000 for research costs and $50,000 for training stroke-clinical researchers per year over the first three years. NIH StrokeNet will allow the most promising therapies to quickly advance to the clinic, to improve prevention, acute treatment, or rehabilitation of the stroke patient, said Dr. Walter J. Koroshetz, deputy director of the institute. Debra Erdley is a staff writer for Trib Total Media. She can be reached at 412-320-7996 or derdley@tribweb.com. You are solely responsible for … Continue reading

Comments Off on Pitt to be part of network to prevent, treat strokes

UC San Diego Joins New NIH Stroke Network

Posted: Published on December 13th, 2013

Contact Information Available for logged-in reporters only Newswise A network of 25 nationally recognized stroke centers has been created to rapidly address the three core features of stroke research and care: prevention, treatment and recovery. The regional coordinating centers (RCCs), working with nearby satellite facilities, will span the country and have teams of researchers representing every stroke-related medical specialty, with the primary goal of bringing new therapies and strategies to the stroke community more rapidly. The centers, which include UC San Diego Health System as a grant recipient, were announced yesterday by the National Institutes of Health. The new system is intended to streamline stroke research, by centralizing approval and review, lessening time and costs of clinical trials, and assembling a comprehensive data sharing system, said Petra Kaufmann, MD, associate director for clinical research at the National Institute of Neurological Disorders and Stroke (NINDS). NINDS, which will fund and manage the NIH Stroke Trials Network, or NIH StrokeNet, has a strong history of successful stroke clinical trials over the past 40 years, leading to critical advances in treatment and prevention of the disease, including the first treatment for acute stroke in 1995, the rt-PA clot-buster. UC San Diego Health System … Continue reading

Comments Off on UC San Diego Joins New NIH Stroke Network

University of Iowa selected for nationwide stroke research network

Posted: Published on December 13th, 2013

The National Institutes of Health chose theUniversity of Iowa, along with 24 other regional stroke centers, to participate in a national research network that aims to improve care for people affected by stroke in Iowa and across the country. The network of stroke centers will have teams research stroke prevention, treatment and recovery.The number of new strokes reported each year is about 795,000, making it the fourth leading cause of death in the United States this number is expected to rise rapidly as the population ages over the next decade. The new system is intended to streamline stroke research by centralizing approval and review, lessening time and costs of clinical trials, and assembling a comprehensive data sharing system, said Dr. Petra Kaufmann, associate director for clinical research at the National Institute of Neurological Disorders and Stroke, in a prepared statement. The institute will fund and manage the NIH Stroke Trials Network, or NIH StrokeNet. Each center will receive five-year funding, with $200,000 in research costs and $50,000 for training stroke clinical researchers, per year over the first three years. Additional funds will be awarded based on the completion of milestones.Dr. Enrique Leira, an associate professor of neurology with UI Health … Continue reading

Comments Off on University of Iowa selected for nationwide stroke research network

Sean Lee Out For Cowboys-Packers Game

Posted: Published on December 13th, 2013

Sean Lee (Photo by Ronald Martinez/Getty Images) IRVING (105.3 THE FAN) The Dallas Cowboys have ruled middle linebacker Sean Lee out for this weekends game against the Packers, reports citing a sprained ligament in his neck. But sources tell 105.3 The Fan that Lee may be undergoing treatment for a neuropraxia-type condition in this case, nerve compression along the spinal cord. This will mark Lees third missed game of this season and the 16th of his possible 62 career games. Lee is well-aware of how his injury absences impact his teams struggling defense. I have to find a way to stay out there, and Ive said that over and over again, Lee said earlier this week, after practicing on Wednesday and Thursday. For me, thats the most frustrating part. I want to be out there in the worst way and I continuously seem to have issues not being on the field. This latest issue occurred Monday in Chicago. Lee injured his neck on the first play of the game, tried to stay in, and in the third quarter got dinged again before leaving. Lee thought he was on-track to participate this week but was absent from Fridays workout. The Cowboys … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Sean Lee Out For Cowboys-Packers Game

Brain Injury Resource Center

Posted: Published on December 13th, 2013

Donate Here "From The Ashes" A Brain Injury Survivor's Guide Captin for Life, autobiography, oF Harry Carson, Legendary Football Hall of Fame linebacker offers high praise for From The Ashes: the original BRAIN injury survivor's guide.Harry WROTE "this book became my Bible. Before I read it I thought I had loss my mind. " Featured on the Super Bowl XXXIV, pre-game show!!! 01/30/00. From The Ashes on sale on Amazon. Used copies priced from $80 to $1,500. OR buy it new here, read it and then sell it on Amazon for a profit. SPECIAL PACKAGE: orders placed on this site receive a free consultation with lead author Constance Miller, as well as an autographed copy of From The Ashes and an educational copy of the 5.5 minute Super Bowl DVD that featured From The Ashes as well as a complimentary caregiver's guide. ONLY $60 U.S. plus postage and handling. We honor Visa , MC, AmEX and PayPal. Call: 206-621-8558 Conferences & Events Brain and Spinal Injury Lawyers UK Head Injury Negligence Lawyers UK In the spirit of "Ideas Worth Spreading" Watch Dr. Jim Olson's TEDx talk on Project Violet at http://www.projectviolet.org, and share it with your friends. The Washington Research … Continue reading

Posted in Brain Injury Treatment | Comments Off on Brain Injury Resource Center

Chief Executive statement: EY Independent Review

Posted: Published on December 13th, 2013

Chief Executive statement: EY Independent Review Doug McKay Chief Executive, Auckland Council 13 December 2013 The EY report released today summarises the findings of their review into the use of council resources and any improper preferential employment treatment, as it relates to the Mayors relationship with Ms Bevan Chuang. I commissioned EY to undertake the review to address concerns that had been raised. This has been an exhaustive and comprehensive review. It addresses the issues that had been raised and I am satisfied that EY has delivered a robust and thorough report. EY was asked to examine: any use of council resources within the Office of the Mayor, in respect of the Mayors relationship with Ms Chuang, that contravenes council policies; any improper preferential treatment in relation to Ms Chuangs engagement as an employee, contractor or an advisor within the Auckland Council Group; and any other issues that the reviewers or Chief Executive considers relate to, or arise out of, the above matters. See the rest here: Chief Executive statement: EY Independent Review … Continue reading

Posted in MS Treatment | Comments Off on Chief Executive statement: EY Independent Review

As Genzyme waits for FDA ruling, its multiple sclerosis drug wins approval in Canada

Posted: Published on December 13th, 2013

By Robert Weisman/Globe Staff/December 13, 2013 As Cambridge biotech Genzyme awaits an upcoming US regulatory decision on its experimental multiple sclerosis drug, the medicine has won approval for sale in Canada. Genzyme said Friday that the regulatory agency Health Canada signed off on its Lemtrada therapy as a treatment for adults with relapsing remitting MS who did not respond to drugs already on the market north of the border. More than 2.3 million people worldwide have been diagnosed with MS, a disease of the central nervous system, including about 100,000 in Canada. Executives at Genzyme, owned by French drug maker Sanofi SA, are expecting a Food and Drug Administration ruling on Lemtrada by Dec. 27. The drug, which figured prominently in Sanofis negotiations to acquire Genzyme in 2011, was approved by European Union regulators in September, boosting to 30 the number of countries where patients have access to the therapy. But its prospects for sale in the United States, the worlds largest market for prescription medicines, are far from certain after an FDA advisory committee meeting last month. The panel of medical specialists convened to advise US regulators focused on safety concerns, such as rashes and bleeding and a higher … Continue reading

Posted in MS Treatment | Comments Off on As Genzyme waits for FDA ruling, its multiple sclerosis drug wins approval in Canada

The Top Five Psychiatry Events of 2013

Posted: Published on December 13th, 2013

Five key events in 2013 will leave a longlasting mark on psychiatry. Here: a look at the impact that CPT coding, DSM-5, sunshine laws, a shrinking market for shrinks, and I-STOP are likely to have on our field. CPT coding and the re-medicalization of psychiatry Starting January 1, 2013, psychiatrists adopted the E&M (evaluation and management) billing codes used by medical colleagues. These billing codes affect more than money and mean more than promises of parity with other medical specialties. Learning coding is confusing and time-consumingbut CPT codes redirect our gaze and change the way psychiatrists think. This may be one of many steps toward ending the supposedly separate but equal categories of mental illness and medical illness. Back in 1977, then-president of the APA Mel Sabshin, MD, urged psychiatrists to return to their medical rootsroots that were frayed by psychoanalysts who deemed medical training unnecessary and accepted lay analysis instead. Change takes time, however. The power and prestige of psychoanalysis faded slowly but surely, but still leaves its legacy. In 2013, the AMA elected a psychiatrist, Jeremy Lazarus, MD, as its president. APA and AMA presidential pronouncements aside, the substance of CPT coding shifts the attention of psychiatrists. Higher … Continue reading

Comments Off on The Top Five Psychiatry Events of 2013

Hormone therapy: MedlinePlus Medical Encyclopedia

Posted: Published on December 13th, 2013

Hormone therapy (HT) uses one or more female hormones, commonly estrogen and progestin and sometimes testosterone, to treat symptoms of menopause. Symptoms of menopause include hot flashes, vaginal dryness, mood swings, sleep disorders, and decreased sexual desire. Hormone therapy comes as a pill, patch, injection, vaginal cream, tablet, or ring. Hormone therapy may help relieve some of the bothersome symptoms of menopause, such as hot flashes, vaginal dryness and pain with intercourse. The hormone estrogen protects against thinning of the bones ( osteoporosis). However, taking hormones may also increase your risk for: You and your doctor should decide whether hormone therapy is right for you. The key is to weigh the risks of taking hormone therapy against the benefits that you might have from taking these hormones. Every woman is different. Your doctor should be aware of your entire medical history before prescribing hormone therapy. At this time, short-term use (up to 5 years) of hormone therapy at the lowest possible dose to treat the symptoms of menopause still appears to be safe for many women. BENEFITS OF HORMONE THERAPY Perhaps the largest benefit women receive from hormone therapy is relief from: Usually, hot flashes and night sweats are less … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Hormone therapy: MedlinePlus Medical Encyclopedia

Page 4,752«..1020..4,7514,7524,7534,754..4,7604,770..»